Sonic / Pediatric ODAC Subcommittee Meeting Vismodegib Genentech Inc. / Ligand / Genentech Inc. / /
Event
FDA Phase / /
IndustryTerm
Cancer Therapy / /
MedicalCondition
pediatric medulloblastoma / WITH BASAL CELL CARCINOMA / tremors / ovarian cancer / Basal Cell Carcinoma / newly diagnosed brain tumors / colorectal and pancreatic cancer / colorectal cancer / paracrine/ligand-dependent tumor / II Ovarian Cancer / medulloblastoma cases / relapsed and refractory medulloblastoma / change body weight Tumor / medulloblastoma / other pediatric tumors / CLINICAL PROGRAM IN ADULT PATIENTS WITH BASAL CELL CARCINOMA / Solid Tumors / fibromas / II Metastatic Colorectal Cancer / early-stage disease / alopecia / metastatic disease / Gorlin syndrome / common skin cancer / colorectal and ovarian cancer / Advanced Basal Cell Carcinoma / follicular cysts / Paracrine-Driven Cancer / adult cancers / actual tumor / ligand-driven tumors / allograft medulloblastoma / common malignant brain tumor / pancreatic cancer / cancers / pancreatic tumor / tumor / I DOSE-ESCALATION STUDY IN ADULTS WITH SOLID TUMORS AND ADVANCED BASAL CELL CARCINOMA Study SHH3925g / malignant tumors / cancer / Tumors / IN CANCER / disease / refractory medulloblastoma / basal cell nevus syndrome / medulloblastoma allograft / non-mutation-driven tumor / involuntary movements / rare autosomal dominant disease / Medulloblastoma / colorectal and ovarian cancers / brain cancer / nonclinical tumor / hypercholesterolemia / /
MedicalTreatment
radiation therapy / chemotherapy / surgery / radiation / Cancer Therapy / /
Organization
National Cancer Institute / Pediatric ODAC Subcommittee / U.S. Food and Drug Administration / Oncologic Drugs Advisory Committee / European Union / Pediatric Oncology Subcommittee / /
Vismodegib Briefing Package: Pediatric ODAC Subcommittee Meeting (1 November 2011)